FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Report a Drug Shortage | Contact Us | FAQ | Background Info | Get Email Alerts | Download Current Drug Shortages

Start Over | Back to Previous Screen

Dextrose 50% Injection
Status: Currently in Shortage
»Date first posted: 01/13/2022
»Therapeutic Categories: Endocrinology/Metabolism; Gastroenterology; Pediatric

Expand all

Amphastar Pharmaceuticals, Inc./IMS (Reverified 05/03/2023)

Company Contact Information:
800-423-4136

Presentation	Availability and Estimated Shortage Duration	Related Information	Shortage Reason (per FDASIA)
25 g/50 mL (0.5 g/mL), syringe, 10 per carton (NDC 76329-3302-1) (old NDC 76329-3301-1)	Backorder due to increase in demand		Demand increase for the drug

Hospira, Inc., a Pfizer company (Revised 05/31/2023)

Company Contact Information:
844-646-4398

Presentation	Availability and Estimated Shortage Duration	Related Information	Shortage Reason (per FDASIA)
25 g/50 mL (0.5 g/mL), plastic syringe, 10 per bundle (NDC 0409-7517-16)	Next Delivery: June 2023; Estimated Recovery: December 2023	Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay Dear Customer Letter: Emergency Syringe Availability Update	Other
25 g/50 mL (0.5 g/mL), glass syringe, 10 per bundle (NDC 0409-4902-34)	Next Delivery: June 2023; Estimated Recovery: December 2023	Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay Dear Customer Letter: Emergency Syringe Availability Update	Other
25 g/50 mL (0.5 g/mL), single dose vial, 25 per tray (NDC 0409-6648-02)	Next Delivery: August 2023; Estimated Recovery: September 2023	Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay	Other